Literature DB >> 18008222

The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries.

Susanne Krüger Kjaer1, Trung Nam Tran, Par Sparen, Laufey Tryggvadottir, Christian Munk, Erik Dasbach, Kai-Li Liaw, Jan Nygård, Mari Nygård.   

Abstract

OBJECTIVE: To assess the burden and correlates of genital warts in women.
METHODS: We conducted a population-based cross-sectional study in 69,147 women (18-45 years of age) randomly chosen from the general population in Denmark, Iceland, Norway, and Sweden. Information on clinically diagnosed genital warts and lifestyle habits was collected using a questionnaire.
RESULTS: Overall, 10.6% reported ever having had clinically diagnosed genital warts. In addition, 1.3% reported having experienced genital warts within the past 12 months. The cumulative incidence for different birth cohorts, estimated on the basis of age at first diagnosis of genital warts, increased with each subsequent younger birth cohort (P<.01). The lifetime number of sex partners was strongly correlated with a history of genital warts (odds ratio for > or =15 partners vs. 1 partner, 9.45 [95% confidence interval, 7.89-11.30]). The likelihood of reporting genital warts also increased with a history of sexually transmitted disease, use of hormonal contraceptives, use of condoms, smoking, and higher education.
CONCLUSIONS: The data suggest that 1 in 10 women in the Nordic countries experience genital warts before the age of 45 years, with an increasing occurrence in younger birth cohorts. These data are important for developing and evaluating strategies (e.g., human papillomavirus [HPV] vaccination) to control and prevent HPV infection and disease in the population.

Entities:  

Mesh:

Year:  2007        PMID: 18008222     DOI: 10.1086/522863

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  62 in total

1.  Anogenital Warts in Childhood - Always a Marker for Sexual Abuse?

Authors:  S Bussen; M Sütterlin; U Schmidt; D Bussen
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-01       Impact factor: 2.915

2.  Teenagers' knowledge about HPV infection and HPV vaccination in the first year of the public vaccination programme.

Authors:  F Sopracordevole; F Cigolot; V Gardonio; J Di Giuseppe; F Boselli; A Ciavattini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-02       Impact factor: 3.267

Review 3.  EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.

Authors:  Marc Arbyn; Silvia de Sanjosé; Mona Saraiya; Mario Sideri; Joel Palefsky; Charles Lacey; Maura Gillison; Laia Bruni; Guglielmo Ronco; Nicolas Wentzensen; Julia Brotherton; You-Lin Qiao; Lynnette Denny; Jacob Bornstein; Laurent Abramowitz; Anna Giuliano; Massimo Tommasino; Joseph Monsonego
Journal:  Int J Cancer       Date:  2012-07-02       Impact factor: 7.396

4.  [Conservative treatment of anogenital HPV infections].

Authors:  G Gross
Journal:  Hautarzt       Date:  2011-01       Impact factor: 0.751

Review 5.  The impact of smoking on HPV infection and the development of anogenital warts.

Authors:  Reto Kaderli; Beat Schnüriger; Lukas E Brügger
Journal:  Int J Colorectal Dis       Date:  2014-06-17       Impact factor: 2.571

Review 6.  [Polyphenon E. A new topical therapy for condylomata acuminata].

Authors:  G Gross
Journal:  Hautarzt       Date:  2008-01       Impact factor: 0.751

7.  Prevalence and correlates of genital warts in Kenyan female sex workers.

Authors:  Barbara E Kavanaugh; Katherine Odem-Davis; Walter Jaoko; Benson Estambale; James N Kiarie; Linnet N Masese; Ruth Deya; Lisa E Manhart; Susan M Graham; Raymond Scott McClelland
Journal:  Sex Transm Dis       Date:  2012-11       Impact factor: 2.830

8.  The quality of life of patients with genital warts: a qualitative study.

Authors:  Gitte Lee Mortensen; Helle K Larsen
Journal:  BMC Public Health       Date:  2010-03-07       Impact factor: 3.295

9.  Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study.

Authors:  Gitte Lee Mortensen
Journal:  BMC Public Health       Date:  2010-02-14       Impact factor: 3.295

10.  Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.

Authors:  Joakim Dillner; Susanne K Kjaer; Cosette M Wheeler; Kristján Sigurdsson; Ole-Erik Iversen; Mauricio Hernandez-Avila; Gonzalo Perez; Darron R Brown; Laura A Koutsky; Eng Hseon Tay; Patricia García; Kevin A Ault; Suzanne M Garland; Sepp Leodolter; Sven-Eric Olsson; Grace W K Tang; Daron G Ferris; Jorma Paavonen; Matti Lehtinen; Marc Steben; F Xavier Bosch; Elmar A Joura; Slawomir Majewski; Nubia Muñoz; Evan R Myers; Luisa L Villa; Frank J Taddeo; Christine Roberts; Amha Tadesse; Janine T Bryan; Roger Maansson; Shuang Lu; Scott Vuocolo; Teresa M Hesley; Eliav Barr; Richard Haupt
Journal:  BMJ       Date:  2010-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.